Portable gluten detection tools are not a substitute for standard care. Used carefully, they may help clinicians support patients when hidden gluten exposure remains a problem. The post The Celiac Care Gap Begins After Diagnosis appeared first on MedCity News.
About a year ago at Erlanger Baroness, the largest hospital in Chattanooga, anesthesia staff noticed that a nurse was slurring his words and struggling to stay awake while on duty in the surgery center, according to a Tennessee Board of Nursing consent order. In the days that followed, the nurse failed a drug test and…
PORT HURON, Mich. — State health officials urged parents in several counties to vaccinate babies against measles ahead of schedule this spring as cases multiplied in Michigan. The outbreaks of the highly contagious virus — which can lead to brain swelling, deafness, and death — came as parents are opting school-age kids out of vaccinations…
By TOMMY BEVERIDGE Just like the Holy Roman Empire was none of those things, America’s health care system is neither health care, nor a system. Both are in fact decentralized commercial arrangements clothed in things that sound good, like Holy-Romanness, or Consumer-driven Health Care. Rather than health care, we have a patchwork of consumer products and government…
Novellia raised $18 million in Series A funding to scale its platform, which helps patients consolidate medical records and share anonymized data with pharma companies. CEO Shashi Shankar argued that sourcing data directly from patients can create more complete healthcare datasets and improve drug research. The post Novellia Snags $18M for Its Real-World Data Platform …
Microsoft to make Mayo Clinic-owned model available through Azure Foundry APIs
Ilant Health’s Series A round was led by Cornucopian Capital, with participation from naturalX, Peakbridge, Semcap AI, Evidenced, Operator Partners, Celtic, LifeX and AlphaLab. The post Ilant Health Raises $15M to Advance Obesity Care appeared first on MedCity News.
Fulcrum Therapeutics drug pociredir posted early clinical trial results showing signs of treating sickle cell disease with no reports of serious complications. But the biotech is discontinuing this program due to FDA concerns that drugs in this class of medicines raise the risk of cancer. The post FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’…
With $50 million commitment, public-benefit company to partner with the Purchaser Business Group on Health and the National Alliance of Healthcare Purchaser Coalitions
Un hombre albanés dijo que el dolor se volvió tan insoportable que se arrancó él mismo un diente mientras languidecía durante meses en un centro de detención de inmigrantes en Nuevo México. Una madre hondureña de dos hijos contó que fue internada por un problema cardíaco después de que le negaran medicamentos para la presión…